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PIH35
DETERMINATION OF COMMUNITY PHARMACY’S DISPENSING COST IN 
MALAYSIA
Shaﬁ e AA, Hassali MA
Universiti Sains Malaysia, Minden, Penang, Malaysia
OBJECTIVES: The main objective of this research is to determine the dispensing cost 
in community pharmacy and to evaluate the factors that affect the costs. METHODS: 
This was a cross sectional study on the community pharmacist in Penang Island. 
Convenient sampling was used whereby 10 community pharmacies in Penang area 
were selected. A 17 items self administered questionnaire was developed consisting of 
question on the type of pharmacy license, pharmacist salary, non pharmacist salary, 
pharmacy’s area size, dispensing’s area size, overhead and capital resources in each 
pharmacy. Cost for dispensing prescription were calculated and Kruskal Wallis test 
was used to compare the dispensing cost with the type of pharmacy license, postcode, 
weekly trading hour and availability of pharmacist personal ofﬁ ce. RESULTS: The 
study found that dispensing cost in a community pharmacy is MYR 0.39 (SD = 0.08) 
per minute. A standard prescription with less than 5 medicines usually takes 10 
minutes of dispensing time and this would cost about MYR 3.91 (SD = 0.80). The 
pharmacist’s salary contributes the highest percentage for the pharmacy dispensing 
cost which was 38.06% followed by rental (24.92%) and non-pharmacist staffs’ salary 
(23.25%). CONCLUSIONS: This study has estimated that the dispensing cost in a 
community pharmacy for a standard prescription to cost about MYR 3.91 (US$1.18). 
The major cost drivers in the pharmacy dispensing cost are pharmacist salary, and 
rent. This study would provide empirical basis for a proper reimbursement structure 
for pharmacy dispensing service in Malaysia. 
PIH36
ASSISTED REPRODUCTIVE TECHNOLOGIES: A HEALTH TECHNOLOGY 
ASSESSMENT PERSPECTIVE
Hiller JE, Elshaug AG, Watt AM, Astute SG
University of Adelaide, Adelaide, South Australia, Australia
OBJECTIVES: Internationally, public funding for assisted reproductive technologies 
(ART) faces constant scrutiny; however the arguments employed—both for and 
against—rarely consider the procedures from a health technology assessment (HTA) 
perspective. This project sought to evaluate the impact of female age, male age and 
cycle rank on the safety, effectiveness and cost-effectiveness of ART through systematic 
reviews. METHODS: Using an a priori protocol, six databases were searched for 
relevant primary studies and existing HTAs. After meeting the inclusion criteria, 
studies underwent appropriate quality assessment and standardised data extraction. 
RESULTS: The review is currently ongoing. The majority of the 70 included studies 
consider the impact of female age on the success of treatment; there are little data 
investigating the contribution of male age or cycle rank to treatment outcome. There 
are substantial ﬂ aws in the evidence base that challenge the application of established 
HTA methods to ART. There is considerable heterogeneity in the evidence base, and 
the policy- and patient-relevant outcome of live birth is not well reported, with many 
studies presenting pregnancy (variously deﬁ ned) as the primary outcome. Many studies 
fail to account for inherent sources of confounding within their patient populations, 
thus rendering outcome estimates unreliable. Despite broadening the scope of the 
review to include national registry data, there remain key questions that cannot be 
conﬁ dently answered with the existing evidence base. The ﬁ nal ﬁ ndings of the review 
will be discussed, alongside their implications for policy-making and public funding 
in this area. CONCLUSIONS: Thirty years of clinical practice in ART has created a 
disparate evidence base that cannot support the application of an evidence-based 
assessment (HTA) framework. ART exempliﬁ es the contextual nature of HTA and 
the challenge to researchers and policymakers in generalizing the evidence from which 
to localize the decision. 
PIH37
RELATIONSHIP BETWEEN HEALTH-CARE PROFESSIONALS ND 
POPULATION HEALTH STATUS: DO NUMBERS COUNT?
Shaﬁ e AA, Hassali MA
Universiti Sains Malaysia, Minden, Penang, Malaysia
OBJECTIVES: This study aims to assess the relationship between the quantity of 
health-care providers, a country income and the health status of population. 
METHODS: This was a cross sectional study on the data collected from World Health 
Organization (WHO) and World Bank database. Only data from 78 countries between 
the years 2003–2008 were selected among the 194 listed countries as they provide the 
most complete data for analysis. Relationship between health-care professionals, coun-
tries’ income and country contributions to neonatal mortality rate, infant mortality 
rate, adult mortality rate, health life expectancy and life expectancy were assessed 
using Spearman correlation analysis in SPSS v15. RESULTS: Most of the countries 
included can be categorized as low income (n = 36), 25 as middle income countries 
and 11 as high income countries. Health-care professionals were found to be uncor-
related with the infant mortality rate of the population except for moderate correlation 
between environment and public health workers (r = −0.31; P < 0.05). The number 
of dentistry personnel was moderately correlated with infant mortality rate, healthy 
life expectancy and life expectancy at birth of both sexes with P < 0.05. A country 
income was however found to have a strong correlation (r = −0.52 to −0.63); P < 
0.05) with all assessed health status indicator. CONCLUSIONS: The number of 
health-care professionals may not play a role as signiﬁ cant as a country income for 
the population overall health. 
PIH38
EVALUATING THE HEALTH TECHNOLOGY ASSESSMENT PROGRAM IN 
THAILAND
Cairns J1, Chalkidou K2, Panpiemras J3, Suriyawongpaisal P4, Yothasamut J5
1London School of Hygiene and Tropical Medicine, London, UK; 2National Institute for 
Health and Clinical Excellence, London, UK; 3Thailand Development Research Institute, 
Wangthonglang, Bangkok, Thailand; 4Faculty of Medicine Ramathibodi Hospital, Ratchatewi, 
Bangkok, Thailand; 5Health Intervention and Techology Assessment Program (HITAP), 
Nonthaburi, Thailand
OBJECTIVES AND METHODS: The review aimed to assess the appropriateness and 
performance of the newly established HTA agency in Thailand. The Health Interven-
tion and Technology Assessment Program (HITAP), a research institute under Thai-
land’s Ministry of Public Health, was formally established in January 2007, to be 
responsible for appraising a wide range of health interventions. During November 
2008 to March 2009, HITAP vision and mission, as well as the program output were 
evaluated by domestic and international experts with logistic assistance from HITAP 
staff. Document reviews, in-depth interviews with key informants, and focus group 
discussion were employed as evaluation methods. RESULTS AND CONCLUSIONS: 
The study found that HITAP has been both effective and efﬁ cient in building up HTA 
capacity and delivering related researches to inform policy decisions in Thailand. A 
key success of HITAP inﬂ uencing policy decisions was that HITAP developed four 
interlink strategies, namely 1) establishing national standards and a body of knowl-
edge for HTA in the country; 2) building up researchers’ competence and organiza-
tional capacity; 3) conducting comprehensive HTA studies using the standard 
methodological guidelines and tools developed within the ﬁ rst strategy; and 4) devel-
oping HTA systems and mechanisms which are effective, transparent, and acceptable 
to stakeholders. It could reasonably be argued that these interlink strategies were 
promising as a means of ﬁ llings the major gaps e.g., lack of research capacity and 
infrastructures for HTA, lack of knowledge /understanding of HTA and mistrust of 
methods among potential users, lack of timely and good quality of evidence. Because 
these similar problems were also identiﬁ ed in other resource-poor settings, experiences 
and lessons learnt from HITAP development are likely to be useful for other low and 
middle income countries interested in setting up HTA agencies. 
INFECTION – Clinical Outcomes Studies
PIN1
SURGICAL SITE INFECTION IN CHINA: A SYSTEMATIC REVIEW OF 
THE INCIDENCE AND ECONOMIC BURDEN
Tan JT1, Coleman K1, Norris S1, Metz L2
1Health Technology Analysts Pty Ltd, Sydney, NSW, Australia; 2Johnson and Johnson Medical 
Asia-Paciﬁ c, Singapore
OBJECTIVES: To conduct a systematic review of literature on the epidemiological 
and economic burden of surgical site infection (SSI) in China. METHODS: A literature 
search of the EMBASE and Medline databases was conducted. The search was limited 
to 1995–2010 to ensure the pertinence of the data. Relevant studies were identiﬁ ed 
using pre-deﬁ ned inclusion criteria (i.e., reports the rate, risk factors, cost of SSI; 
conducted in a hospital setting; not an intervention study). Data on the prevalence, 
incidence, risk factors and cost of SSI were extracted. Searches to identify epidemio-
logical and economic studies were conducted separately. RESULTS: The literature 
search identiﬁ ed six publications, comprising three studies conducted in Beijing (N = 
95 to 196), one in Shandong (N = 2126), and two in Guangdong (N = 13,798). The 
incidence of SSI varied with surgical procedure. High incidence rates of SSI were 
reported for laryngectomy (21.1%), general surgery (18.8%), thoracic surgery 
(13.9%) and bone surgery (11.2%); while the rates for pancreas surgery (7.1%), 
neurosurgery (3%) and caesarean section (0.7%) appeared lower. The included studies 
found that risk factors such as wound classiﬁ cation, BMI and use of antibiotics sig-
niﬁ cantly increased the risk of SSI. SSI was associated with a signiﬁ cant increase in 
neoplasm recurrence following laryngectomy (35% vs. 5.3%, P < 0.001), and 
extended postoperative hospital stay by an average of 33.6 days. The additional cost 
experienced by patients who developed a SSI was estimated at RMB 17,332/patient. 
CONCLUSIONS: SSI has the potential to represent a substantial burden on the health-
care system and patients in China, mainly attributable to the extended length of stay 
in hospital and additional cost of treatment required. Interventions aimed at reducing 
SSI would provide cost-savings to the health-care system and improve its efﬁ ciency. 
PIN2
SURGICAL SITE INFECTION IN INDIA: A SYSTEMATIC REVIEW OF THE 
INCIDENCE AND ECONOMIC BURDEN
Tan JT1, Coleman K1, Norris S1, Mapari J2, Shastri S2, Metz L3
1Health Technology Analysts Pty Ltd, Sydney, NSW, Australia; 2Johnson and Johnson 
Medical, Mahim, Mumbai, India; 3Johnson and Johnson Medical Asia-Paciﬁ c, Singapore
OBJECTIVES: To conduct a systematic review of literature on the epidemiological 
and economic burden of surgical site infection (SSI) in India. METHODS: A literature 
search of the EMBASE and Medline databases was conducted. The search was limited 
to 1995–2010 to ensure the pertinence of the data. Searches to identify epidemiological 
and economic studies were conducted separately. Relevant studies were identiﬁ ed 
using pre-deﬁ ned criteria (i.e., reports the rate, risk factors, cost of SSI; conducted in 
a hospital setting; not an intervention study). RESULTS: Twelve studies met the inclu-
sion criteria and are presented in this review. The overall incidence of SSI in India is 
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approximately 10%. The rates of SSI varied depending on the surveillance period, 
data collection method, and surgical procedure. The incidence of SSI was high for 
cardiovascular (5–18%) and gastrointestinal (6–16%) surgery. The rates of SSI 
appeared lower for neurosurgery (0.8–2.5%), although those studies only considered 
SSI cases before discharge from hospital. Diabetes and obesity were found to increase 
the risk of SSI by over 70%. Other signiﬁ cant risk factors identiﬁ ed include surgery 
duration and wound classiﬁ cation. The most common pathogens in SSIs were Staphy-
lococcus aureus, Pseudomonas aeruginosa and Escherichia coli. SSIs were found to 
extend hospital stay by 5–18 days and increase treatment cost by 4–30%. The esti-
mated cost of hospitalization was signiﬁ cantly higher in patients with SSI compared 
to patients without SSI (29,000 vs. 16,000 rupees, P < 0.001). CONCLUSIONS: In 
India, where an estimated 72% of health-care expense is out-of-pocket, the additional 
cost associated with SSI (treatment, loss of ability to work) represents a signiﬁ cant 
burden to patients and their families. The increase in hospital stay also lays additional 
burden to an already resource-constrained health-care system. Interventions aimed at 
reducing SSI would provide cost-savings and improve the efﬁ ciency of the health-care 
system. 
PIN3
SURGICAL SITE INFECTION IN AUSTRALIA: A SYSTEMATIC REVIEW 
OF THE INCIDENCE AND ECONOMIC BURDEN
Coleman K1, Tan JT1, Norris S1, Hardy K2, Berg T2, Metz L3
1Health Technology Analysts Pty Ltd, Sydney, NSW, Australia; 2Johnson and Johnson Medical 
Australia, Sydney, NSW, Australia; 3Johnson and Johnson Medical Asia-Paciﬁ c, Singapore
OBJECTIVES: To conduct a systematic review of literature on the epidemiological 
and economic burden of surgical site infection (SSI) in Australia. METHODS: A lit-
erature search of the EMBASE and Medline databases was conducted. The search was 
limited to 1995–2010 to ensure the pertinence of the data. Searches to identify epide-
miological and economic studies were conducted separately. Relevant studies were 
identiﬁ ed using pre-deﬁ ned criteria (i.e., reports the rate, risk factors, cost of SSI; 
conducted in a hospital setting; not an intervention study). RESULTS: Thirty-ﬁ ve 
studies were included in this review. Differences in study design (surveillance period, 
data collection method, surgical procedure) made it difﬁ cult to synthesise data to 
derive a single estimate of SSI in Australia. The overall incidence of SSI in Australia 
is approximately 5–10%. However, the rate of SSI varied across different procedures: 
higher rates were seen following gastrointestinal (~11%) and cardiovascular (6–13%) 
surgery, while the rates for orthopedic (4.7–8%) and gynecological surgery (2.3–10%) 
appeared lower. Risk factors identiﬁ ed include diabetes and obesity, which increased 
the risk of SSI by 60–180%. The National Nosocomial Infections Surveillance (NNIS) 
risk index was positively correlated with the risk of developing an SSI. The most 
common organisms identiﬁ ed in SSIs were Staphylococcus aureus and Pseudomonas 
aeruginosa. The hospitalization cost attributable to SSI is estimated at approximately 
AUD$54 million annually. With a large proportion of SSIs occurring after discharge 
from hospital, the incidence of SSI is likely underestimated. Post-discharge SSI, in turn, 
increases the burden to community health services. Indirect costs, such as loss of 
productivity, further add to the economic burden of SSI. CONCLUSIONS: The 
incidence and cost estimates demonstrate that SSI represents a signiﬁ cant burden to 
the Australian health-care system. Interventions aimed at reducing SSI would provide 
cost-savings and improve the efﬁ ciency of the health-care system. 
PIN4
SURGICAL SITE INFECTION IN JAPAN: A SYSTEMATIC REVIEW OF THE 
INCIDENCE AND ECONOMIC BURDEN
Tan JT1, Coleman K1, Norris S1, Maki A2, Metz L3
1Health Technology Analysts Pty Ltd, Sydney, NSW, Australia; 2Johnson and Johnson Medical 
K.K., Chiyoda-ku, Tokyo, Japan; 3Johnson and Johnson Medical Asia-Paciﬁ c, Singapore
OBJECTIVES: To conduct a systematic review of literature on the epidemiological 
and economic burden of surgical site infection (SSI) in Japan. METHODS: A literature 
search of the EMBASE and Medline databases was conducted. The search was limited 
to 1995–2010 to ensure the pertinence of the data. Searches to identify epidemiological 
and economic studies were conducted separately. Relevant studies were identiﬁ ed 
using pre-deﬁ ned criteria (i.e., reports the rate, risk factors, cost of SSI; conducted in 
a hospital setting; not an intervention study). RESULTS: Thirty-ﬁ ve studies (22 ret-
rospective, 12 prospective and one case-control study) were included. Differences in 
study design, surgical procedure and surveillance period made it difﬁ cult to synthesise 
data to derive a single estimate of SSI in Japan. The overall incidence of SSI in Japan 
is approximately 5–10%. The rate of SSI was higher following gastrointestinal surgery 
(~20%), and lower for cardiovascular (<6.5%) and orthopedic (<1%) surgery. Super-
ﬁ cial SSI occurred most frequently accounting for 30–87% of all SSIs. The National 
Nosocomial Infections Surveillance (NNIS) risk index was positively correlated with 
the risk of developing an SSI. Procedure-associated risk factors (e.g., surgical tech-
nique, surgery duration) were also found to signiﬁ cantly increase the risk of SSI. The 
most common organisms identiﬁ ed in SSIs were Staphylococcus aureus and Pseudo-
monas aeruginosa. None of the studies identiﬁ ed in this review examined the economic 
burden of SSI in Japan. However, several studies showed that SSIs were associated 
with a signiﬁ cant increase in ICU and hospital stay (6–27 additional days). CONCLU-
SIONS: SSI represents a substantial burden on the health-care system and patients, 
mainly attributable to the extended length of stay in hospital and additional cost of 
treatment required. Consequently, strategies and interventions aimed at reducing the 
incidence of SSIs could provide cost-savings and improve the efﬁ ciency of the Japanese 
health-care system. 
PIN6
COMPARISON OF SOCIO-DEMOGRAPHIC AND CLINICAL FACTORS OF 
PULMONARY AND EXTRA PLUMONARY TUBERCULOSIS IN YEMEN
Othman GQ, Ibrahim MI
Universiti Sains Malaysia, Penang, Malaysia
OBJECTIVES: The study aimed to assess the clinical and socio-demographic factors 
associated with pulmonary and extra pulmonary tuberculosis in Yemen. METHODS: 
A cross-sectional study was carried out among 160 Pulmonary Tuberculosis (PTB) 
and 160 Extra Pulmonary Tuberculosis (EPTB) patients diagnosed and treated in a 
TB center in Sana’a, the capital city of Yemen. Socio demographic, clinical and labora-
tory data and types of drug regimen used in treatment were collected from TB patients 
and medical records from the TB center. Risk factors for EPTB patients and PTB 
patients were identiﬁ ed through structured questionnaire by interviewing. RESULTS: 
The female to male ratio was 1.2 and 1.6 for PTB and EPTB, respectively. The median 
age for PTB patients was 28 and 30 for EPTB patients. It was also found that the TB 
patients with low educational level amounted 52% and 49% in PTB and EPTB 
respectively. This study illustrated that the majority of smokers were males 64% for 
PTB and 58% for EPTB, whose age ranging between 15–54 in both PTB and EPTB 
cases. This study found the extra pulmonary tuberculosis patients diagnosed in private 
hospital and clinics (41%) more than pulmonary tuberculosis patients (26%) There 
were signiﬁ cant differences in vaccination in case of employed patients of PTB than 
non employed patients and educated patients of PTB than non educated patients (P 
= 0.02 and P = 0.036) respectively. There was also signiﬁ cant difference in vaccination 
in case of employed patients of EPTB than nonemployed patients (P < 0.0001). 
CONCLUSIONS: In conclusion, female and younger ages were higher in both EPTB 
and PTB. The EPTB patients diagnosed in private hospital and clinics were more than 
PTB patients. The EPTB patients have less monthly income than pulmonary TB. Vac-
cination has strong correlation with education and employment in case of PTB and 
EPTB patients. 
PIN7
ANTIFUNGAL TREATMENT FOR INVASIVE CANDIDIASIS: SYSTEMATIC 
REVIEW AND META-ANALYSIS
Oh JJ1, Hwang JA2, Ko SK1
1Pﬁ zer Pharmaceuticals Korea Ltd, Seoul, South Korea; 2Korea Environment Health Institute, 
Seoul, South Korea
OBJECTIVES: This study aimed to compare the effects of different antifungal thera-
pies for invasive candidiasis. METHODS: Literature searches through MEDLINE, and 
the Cochrane Database were performed with the following search terms: names of 
speciﬁ c antifungal agents, candidiasis and candidemia, from inception to December 
2009. We included all randomized controlled trials (RCT), observational studies, 
cohort studies and review articles that compared different antifungal agents for the 
treatment of invasive candidiasis and other form of candidiasis. Then we performed 
a meta-analysis with extracted RCTs. The primary outcome was treatment success 
and the secondary outcome was all-cause mortality. Relative risks (RRs) with 95% 
conﬁ dence intervals (Cis) were pooled. RESULTS: Through systematic review (SR), a 
total number of nine RCTs, four SR and meta-analysis, one observational study were 
extracted. Meta-analysis included nine RCTs enrolling a total of 1527 patients. For 
primary analysis of treatment success, we pooled 5 trials comparing ﬂ uconazole to 
amphotericin B, Relative Risk (RR) 0.92 (95% CI, 0.81–1.03). We also pooled two 
trials of amphotericin B versus echinocandins and yielded a RR of 1.00 (95% CI, 
0.90–1.10). One study compared anidulafungin to ﬂ uconazole resulting in a RR of 
1.26 (95% CI, 1.06–1.51) in favor of anidulafungin. For all-cause mortality analysis, 
ﬁ ve trials assessing ﬂ uconazole to amphotericin B were pooled and yielded a RR of 
0.84 (95% CI, 0.64–1.12). The pooled RR of two trials comparing amphotericin B 
to echinocandins was 0.95 (95% CI, 0.73–1.23). Anidulafungin versus ﬂ uconazole 
resulted in a RR of 0.73 (95% CI, 0.48–1.10). CONCLUSIONS: All assessed anti-
fungal agents showed similar efﬁ cacy on treatment success and all-cause mortality, 
but anidulafungin revealed the signiﬁ cant high rate of treatment success compared to 
ﬂ uconazole. 
PIN8
CLINICAL EFFECTIVENESS OF THE SEASONAL INFLUENZA VACCINE 
IN HEALTHY INDIAN CHILDREN
Singh H1, Gupta G2, Tiwari P3
1National Institute of Pharmaceutical Education and Research (NIPER), S.A.S. Nagar, Sec-67, 
Punjab, India; 2Charak Care Clinics, Mohali, Punjab, India, 3National Institute of 
Pharmaceutical Education and Research, Mohali, Punjab, India
OBJECTIVES: To evaluate the clinical effectiveness of the 2009–2010 seasonal inﬂ u-
enza vaccine in preventing Inﬂ uenza-like illness (ILI) in healthy Indian children of age 
6 months to 18 years. METHODS: A prospective observational cohort study was 
carried out from September, 2009 to February, 2010, at a private outpatient pediatric 
setting in Northern India. All the enrolled children were followed monthly through 
telephonic interview of their parents for development of ILI. The visits to physician 
for any acute respiratory tract infection (ARI) were also recorded. ILI was deﬁ ned as 
per ICD-10. Children having one shot and two shots of inﬂ uenza vaccine were deﬁ ned 
as partially vaccinated and fully vaccinated, respectively. Multiple logistic regression 
was used to calculate the association between vaccination status and ILI. RESULTS: 
A total of 294 children, vaccinated cohort (N = 153) and unvaccinated cohort (N = 
141) were enrolled in the study. There was a statistically signiﬁ cant reduction in ILI 
(OR 0.57 [0.33–0.99], P < 0.05) and visits to physician for ARI (OR 0.42 [0.22–0.79], 
